Hematologic malignancies were the first human cancers to be studied in depth at the molecular level, and recent years have seen important advances in treatment.

Since the late 1960s, the survival rate in children and adolescents diagnosed with cancer has steadily improved, with a corresponding decline in the cancer-spec

MDS/MPN With Ring Sideroblasts and Thrombocytosis

Hematologic malignancies were the first human cancers to be studied in depth at the molecular level, and recent years have seen important advances in treatment.

The aim of Hematologic Malignancies: Methods and Techniques is to review those methods most useful for the diagnosis and subsequent mana- ment of hematologic ma